BrightHeart Unveils Breakthrough AI Results at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, Revolutionizing Prenatal Care

Paris, France – January 31, 2025, BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, presented two groundbreaking studies during the oral plenary and concurrent sessions on January 30th at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting, held in Aurora, Colorado. As the first major unveiling of the BrightHeart technology and presentation of key clinical results, these sessions drove significant enthusiasm for BrightHeart’s potential to transform prenatal care.

BrightHeart’s innovative AI technology addresses a critical unmet clinical need, targeting the significant challenge of screening for congenital heart defects (CHDs), the most common type of birth defect. Currently, up to 70% of CHD cases go undetected during routine prenatal ultrasounds due to the complexity of these exams. Formally unveiled in the SMFM 2025 presentation sessions, BrightHeart’s AI software demonstrated the potential to dramatically reduce these missed diagnoses and revolutionize care in the obstetric space.

Read more…